PSMA represents an excellent target for imaging of PCa, as its expression is drastically elevated in 90%-100% of local PCa lesions, tumorous lymph nodes, and metastatic bone lesions 14-16. This evidence concerns the gene FOLH1 and posterior cortical atrophy.